In patients with HF cardiac output, metabolism and endothelial function will be studied during and after treatment with ghrelin infusion
In patients with HF cardiac output, metabolism and endothelial function will be studied during and after treatment with ghrelin infusion (single dose). The following parameters will be collected: routine clinical parameters, endothelial function, cardiac structure and function by echocardiography, non-invasively assessed cardiac output and hemodynamics, serologic and of cardiac and renal function, sympathetic and RAS activation, metabolism, anabolic hormone function, inflammation, fibrosis, oxidative stress and apoptosis. 15 patients each group in are adequate to detect a difference between groups and before vs after ghrelin administration in metabolism, anabolic function and endothelial function with a power of 90% and two-sided significance of 5%.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
31
Change in cardiac output between treament groups
Assessed by non-invasive inert gas rebreathing technique (L/min)
Time frame: Procedure (At the end of ghrelin administration)
Change in endothelial function between treament groups
Assessed non-invasive by flow mediated dilatory capability of the brachial artery (mm)
Time frame: Procedure (At the end of ghrelin administration)
Change in cardiac function between treament groups
Assessed by echocardiography (left ventricular ejection fraction, strain, TAPSE)
Time frame: Procedure (At the end of ghrelin administration)
GH biomarker
Circulating biomarkers (GH)
Time frame: Procedure (At the end of ghrelin administration)
ghrelin biomarker
Circulating biomarkers ( ghrelin)
Time frame: Procedure (At the end of ghrelin administration)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.